LL-37 Research for Skin Infections
An evidence-based overview of research examining LL-37 in the context of skin infections. This page synthesizes findings from peer-reviewed literature.
Research Summary
LL-37 is naturally expressed in skin and plays a key role in cutaneous innate immunity. The peptide is upregulated in response to skin infection and injury. Deficiency in LL-37 expression is associated with increased susceptibility to skin infections. Topical application has shown antimicrobial effects in preclinical models. Clinical applications may include treatment of infected wounds, diabetic ulcers, and chronic skin infections resistant to conventional antibiotics.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Skin Infections
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. LL-37 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.